Trial intelligence / Profile preview

Impact of n-3 Polyunsaturated Fatty Acids on Adipose Tissue Inflammation in Morbidly Obese Patients

2006-005287-94Phase 2Completed

Sponsor
Medical University of Vienna
Start
Mar 2008
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 2 trial of omega-3-acid triglycerides in class III obesity, sponsored by Medical University of Vienna. Primary endpoint: Change in inflammatory parameters in visceral adipose tissue. Started Mar 2008; status: completed.

02

Drugs

omega-3-acid triglycerides
03

Conditions

class III obesity

Beyond the preview

Go deeper on 2006-005287-94.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-005287-94.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call